Details for New Drug Application (NDA): 062226
✉ Email this page to a colleague
NDA 062226 describes LAROTID, which is a drug marketed by Glaxosmithkline and Us Antibiotics and is included in two NDAs. Additional details are available on the LAROTID profile page.
The generic ingredient in LAROTID is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
The generic ingredient in LAROTID is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 062226
| Tradename: | LAROTID |
| Applicant: | Us Antibiotics |
| Ingredient: | amoxicillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062226
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 125MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 125MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
